Cargando…
The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease
The adenosine A(2A) receptor (A(2A)R), dopamine D(2) receptor (D(2)R) and metabotropic glutamate receptor type 5 (mGluR(5)) form A(2A)R-D(2)R-mGluR(5) heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463353/ https://www.ncbi.nlm.nih.gov/pubmed/35829830 http://dx.doi.org/10.1007/s12035-022-02946-9 |
_version_ | 1784787379023773696 |
---|---|
author | Romero-Fernandez, Wilber Taura, Jaume J. Crans, René A. J. Lopez-Cano, Marc Fores-Pons, Ramon Narváez, Manuel Carlsson, Jens Ciruela, Francisco Fuxe, Kjell Borroto-Escuela, Dasiel O. |
author_facet | Romero-Fernandez, Wilber Taura, Jaume J. Crans, René A. J. Lopez-Cano, Marc Fores-Pons, Ramon Narváez, Manuel Carlsson, Jens Ciruela, Francisco Fuxe, Kjell Borroto-Escuela, Dasiel O. |
author_sort | Romero-Fernandez, Wilber |
collection | PubMed |
description | The adenosine A(2A) receptor (A(2A)R), dopamine D(2) receptor (D(2)R) and metabotropic glutamate receptor type 5 (mGluR(5)) form A(2A)R-D(2)R-mGluR(5) heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A(2A)R protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D(2)R-mGluR(5) heteromeric component of the A(2A)R-D(2)R-mGluR(5) complex in vitro and in vivo. The A(2A)R and mGluR(5) protomers interact and modulate D(2)R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A(2A)R in HEK293T cells co-expressing D(2)R and mGluR(5) resulted in a significant and marked increase in the formation of the D(2)R-mGluR(5) heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D(2)R (D2R(Ki High)) values was found upon cotreatment with the mGluR(5) and A(2A)R agonists in the cells expressing A(2A)R, D(2)R and mGluR(5) with a significant effect observed also with the mGluR(5) agonist alone compared to cells expressing only D(2)R and mGluR(5). In cells co-expressing A(2A)R, D(2)R and mGluR(5), stimulation of the cells with an mGluR(5) agonist like or D(2)R antagonist fully counteracted the D(2)R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR(5) and D(2)R. In agreement, the mGluR(5)-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A(2A)R knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR(5) and A(2A)R in enhancing D(2)R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-022-02946-9. |
format | Online Article Text |
id | pubmed-9463353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-94633532022-09-11 The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease Romero-Fernandez, Wilber Taura, Jaume J. Crans, René A. J. Lopez-Cano, Marc Fores-Pons, Ramon Narváez, Manuel Carlsson, Jens Ciruela, Francisco Fuxe, Kjell Borroto-Escuela, Dasiel O. Mol Neurobiol Article The adenosine A(2A) receptor (A(2A)R), dopamine D(2) receptor (D(2)R) and metabotropic glutamate receptor type 5 (mGluR(5)) form A(2A)R-D(2)R-mGluR(5) heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A(2A)R protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D(2)R-mGluR(5) heteromeric component of the A(2A)R-D(2)R-mGluR(5) complex in vitro and in vivo. The A(2A)R and mGluR(5) protomers interact and modulate D(2)R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A(2A)R in HEK293T cells co-expressing D(2)R and mGluR(5) resulted in a significant and marked increase in the formation of the D(2)R-mGluR(5) heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D(2)R (D2R(Ki High)) values was found upon cotreatment with the mGluR(5) and A(2A)R agonists in the cells expressing A(2A)R, D(2)R and mGluR(5) with a significant effect observed also with the mGluR(5) agonist alone compared to cells expressing only D(2)R and mGluR(5). In cells co-expressing A(2A)R, D(2)R and mGluR(5), stimulation of the cells with an mGluR(5) agonist like or D(2)R antagonist fully counteracted the D(2)R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR(5) and D(2)R. In agreement, the mGluR(5)-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A(2A)R knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR(5) and A(2A)R in enhancing D(2)R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-022-02946-9. Springer US 2022-07-12 2022 /pmc/articles/PMC9463353/ /pubmed/35829830 http://dx.doi.org/10.1007/s12035-022-02946-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Romero-Fernandez, Wilber Taura, Jaume J. Crans, René A. J. Lopez-Cano, Marc Fores-Pons, Ramon Narváez, Manuel Carlsson, Jens Ciruela, Francisco Fuxe, Kjell Borroto-Escuela, Dasiel O. The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title | The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title_full | The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title_fullStr | The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title_full_unstemmed | The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title_short | The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease |
title_sort | mglu(5) receptor protomer-mediated dopamine d(2) receptor trans-inhibition is dependent on the adenosine a(2a) receptor protomer: implications for parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463353/ https://www.ncbi.nlm.nih.gov/pubmed/35829830 http://dx.doi.org/10.1007/s12035-022-02946-9 |
work_keys_str_mv | AT romerofernandezwilber themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT taurajaumej themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT cransreneaj themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT lopezcanomarc themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT foresponsramon themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT narvaezmanuel themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT carlssonjens themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT ciruelafrancisco themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT fuxekjell themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT borrotoescueladasielo themglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT romerofernandezwilber mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT taurajaumej mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT cransreneaj mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT lopezcanomarc mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT foresponsramon mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT narvaezmanuel mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT carlssonjens mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT ciruelafrancisco mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT fuxekjell mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease AT borrotoescueladasielo mglu5receptorprotomermediateddopamined2receptortransinhibitionisdependentontheadenosinea2areceptorprotomerimplicationsforparkinsonsdisease |